- Generating clinical evidence using digitally simulated ‘predicted outcomes’
- Fully harnessing the power of simulation in each phase of the trial and utilizing AI tools to implement knowledge gained from real-world data
Speaker(s):
Tina Morrison
Director, Office of Regulatory Science and Innovation
FDA